Advanced Sterilization Products (ASP), part of Johnson & Johnson Medical Devices Companies, announces that it submitted a 510(k) application to the Food and Drug Administration (FDA) for the ultra-fast STERRAD VELOCITY™ Biological Indicator (BI) System. Pending clearance, it will be the fastest hydrogen peroxide (H202) BI on the market, using a new, integrated reader to provide automated confirmation – within 30 minutes – that proper sterilization conditions have been achieved when instruments are reprocessed in STERRAD® Systems.
Ensuring instruments are properly sterilized is one way healthcare workers can help reduce the incidences of healthcare-associated infections (HAI). According to the Centers for Disease Control and Prevention, about one in every 25 hospitalized patients acquires at least one HAI.1 HAIs cause an estimated 75,000 deaths in the United States per year, with total annual costs amounting to almost $10 billion annually.
Given the constant demands placed on hospital operating rooms, speed and efficiency of in-house Central Sterile Services Departments (CSSDs) are critical to supplying properly reprocessed medical devices as needed. In CSSDs, BIs are used to test and confirm sterilization cycle performance and provide sterility assurance. However, with current BIs taking several hours or more to confirm results, many instruments are sent back to operating rooms without sterility assurance.
"For more than 20 years, the biggest need we have heard from CSSDs and infection control departments is for a BI that provides almost immediate confirmation of sterility assurance," said Suneel Shorey, vice president of ASP Global Marketing. "An ultra-fast system will help staff ensure every instrument has been properly sterilized and can be swiftly delivered back to the operating room to be used with patients."
The STERRAD VELOCITY™ BI Reader will enable synchronization of BI and sterilization cycle records through a barcode scanner and touchscreen. It will also feature a countdown display for each well and on-screen and audible alerts. The reader will be validated for use with the recently FDA-cleared STERRAD® 100NX® and NX® Systems with ALLClear™ Technology, as well as existing STERRAD® NX, 100NX® and 100S® System sterilizers.
Source: Advanced Sterilization Products
The Sterile Processing Conference Survival Guide: How to Make the Most of Your Next Event
March 25th 2025From expert speakers to cutting-edge tools, sterile processing conferences, like the 2025 HSPA Annual Conference and the SoCal SPA's Spring Conference, offer unmatched opportunities to grow your skills, expand your network, and strengthen your department's infection prevention game.
Redefining Material Compatibility in Sterilization: Insights From AAMI TIR17:2024
March 24th 2025AAMI TIR17:2024 provides updated, evidence-based guidance on material compatibility with sterilization modalities. It offers essential insights for medical device design and ensures safety without compromising functionality.
The Latest on CLABSIs and CAUTIs: Evidence-Based Approaches for Infection Prevention
February 27th 2025Health care–associated infections like CLABSIs and CAUTIs threaten patient safety. Learn evidence-based strategies, new technologies, and prevention protocols to reduce these infections and improve outcomes.